The efficacy of gastrectomy for large gastric cancer

International Journal of Clinical Oncology

Volumn 11, Issue 1, 2006, Pages 44-50

  Kobayashi, Osamu ^a   Tsuburaya, Akira ^a   Yoshikawa, Takaki ^a   Osaragi, Tomohiko ^a   Murakami, Hitoshi ^a   Yoshida, Tatsuya ^a   Sairenji, Motonori ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Gastrectomy; Gastric cancer; Recurrence; Survival

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; GASTRECTOMY; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION; TREATMENT INDICATION;

GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33644621011     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-005-0535-4     Document Type: Article

References (28)

1. K Maruyama K Okabayashi T Kinoshita 1987 Progress in gastric cancer surgery in Japan and its limits of radicality World J Surg 11 418 425
2. F Roviello D Marrelli G Manzoni 2003 Prospective study of peritoneal recurrence after curative surgery for gastric cancer Br J Surg 90 1113 1119
3. Y Yamamura T Nakajima K Ohta 2002 Determining prognostic factors for gastric cancer using the regression tree method Gastric Cancer 5 201 207
4. Y Maehara H Oiwa S Oda 1995 Surgical treatment and prognosis for patients with gastric cancer lesions larger than 10∈cm in size Oncology 52 35 40
5. Y Sakata A Ohtsu N Horikoshi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1∈M tegafur-0.4∈M gimestat-1∈M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
6. W Koizumi M Kurihara S Nakano 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer Oncology 58 191 197
7. H Cho A Tsuburaya O Kobayashi 2003 Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1 Gastric Cancer 6 Suppl 1 24 27
8. W Koizumi S Tanabe K Saigenji 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212
9. JD Roder K Boettcher JR Siewert 1998 Classification of regional lymph node metastasis from gastric carcinoma Cancer 82 621 631
10. A Nashimoto H Yabusaki O Tanaka 1999 Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors: a phase II study with 5-fluorouracil, leucovorine, and cisplatin Gastric Cancer 2 57 63
11. Japanese Gastric Cancer Association 1998 Japanese classification of gastric carcinoma - 2nd English edition Gastric Cancer 1 10 24
12. LH Sobin CH Wittekind 1997 TNM classification of malignant tumors. International Union Against Cancer 5th edn. John Wiley & Sons New York
13. T Yokota S Ishiyama T Saito 2002 Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 22 3673 3677
14. S Moriguchi Y Maehara D Korenaga 1992 Prediction of survival time after curative surgery for advanced gastric cancer Eur J Surg Oncol 18 287 292
15. Y Adachi T Oshiro M Mori 1997 Tumor size as a simple prognostic indicator for gastric carcinoma Ann Surg Oncol 4 137 140
16. T Yoshikawa A Tsuburaya O Kobayashi 2001 Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators Hepatogastroenterology 48 1509 1512
17. JA Ajani RJ Mayer DM Ota 1993 Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma J Natl Cancer Inst 85 1839 1844
18. A Ohtsu Y Shimada K Shirao 2003 Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54 59
19. H Katai K Yoshimura K Maruyama 2000 Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma Cancer 88 1796 1800
20. H Baba T Okuyama H Orita 1992 Prognostic factors for noncurative gastric cancer: univariate and multivariate analyses J Surg Oncol 51 104 108
21. H Iwase M Shimada T Tsuzuki 2005 A phase II multicentric trial of S-1 combined with 24-h infusion of cisplatin in patients with advanced gastric cancer Anticancer Res 25 1297 1302
22. A Nashimoto T Nakajima H Furukawa 2003 Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1 J Clin Oncol 21 2282 2287
23. K Yasuda N Shiraishi Y Adachi 2001 Risk factors for complications following resection of large gastric cancer Br J Surg 88 873 8772
24. H Wilke P Preusser U Fink 1989 Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin J Clin Oncol 7 1318 1326
25. S Cascinu M Scartozzi R Labianca 2004 High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) Br J Cancer 90 1521 1525
26. H Yabusaki A Nashimoto O Tanaka 2003 Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer (in Japanese) Gan To Kagaku Ryouho 30 1933 1940
27. I Songun HJ Keizer J Herman 1999 Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial Eur J Cancer 35 558 562
28. T Kinoshita M Konishi T Nakagohri 2003 Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study Gastric Cancer 6 Suppl 1 40 44